Search research articles
Contact Us
Filters
Showing results (131-140 of 191) with videos related to
Page
of 20
Sort By:
Nature Reviews. Neurology
|
January 30, 2018
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, et al.
Journal of Alzheimer'S Disease : JAD
|
February 19, 2010
Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry
Matthew J Sharman, Guanghou Shui, Aaron Z Fernandis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 30, 2022
Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease
Emilie L Castranio, Philip Hasel, Jean-Vianney Haure-Mirande, et al.
Mechanisms of Ageing and Development
|
March 24, 2004
Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta)
Sam Gandy, Ron B DeMattos, Cynthia A Lemere, et al.
Alzheimer Disease and Associated Disorders
|
June 16, 2004
Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta)
Sam Gandy, Ron B DeMattos, Cynthia A Lemere, et al.
The Journal of Comparative Neurology
|
January 14, 2014
Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model
John W Steele, Hannah Brautigam, Jennifer A Short, et al.
Acta Neuropathologica Communications
|
October 29, 2017
CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 <sup>N141I</sup> neurons
Maitane Ortiz-Virumbrales, Cesar L Moreno, Ilya Kruglikov, et al.
Molecular Neurodegeneration
|
December 19, 2009
Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo
John W Steele, Soong H Kim, John R Cirrito, et al.
Translational Psychiatry
|
March 17, 2022
Reduced cerebellar cortical thickness in World Trade Center responders with cognitive impairment
Sean A P Clouston, Minos Kritikos, Chuan Huang, et al.
Journal of Alzheimer'S Disease : JAD
|
August 14, 2022
DTI Connectometry Analysis Reveals White Matter Changes in Cognitively Impaired World Trade Center Responders at Midlife
Minos Kritikos, Chuan Huang, Sean A P Clouston, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 191) with videos related to
Sort By:
Page
of 20
Nature Reviews. Neurology
|
January 30, 2018
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E Arnold, Zoe Arvanitakis, Shannon L Macauley-Rambach, et al.
Journal of Alzheimer'S Disease : JAD
|
February 19, 2010
Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry
Matthew J Sharman, Guanghou Shui, Aaron Z Fernandis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 30, 2022
Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease
Emilie L Castranio, Philip Hasel, Jean-Vianney Haure-Mirande, et al.
Mechanisms of Ageing and Development
|
March 24, 2004
Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta)
Sam Gandy, Ron B DeMattos, Cynthia A Lemere, et al.
Alzheimer Disease and Associated Disorders
|
June 16, 2004
Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta)
Sam Gandy, Ron B DeMattos, Cynthia A Lemere, et al.
The Journal of Comparative Neurology
|
January 14, 2014
Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model
John W Steele, Hannah Brautigam, Jennifer A Short, et al.
Acta Neuropathologica Communications
|
October 29, 2017
CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 <sup>N141I</sup> neurons
Maitane Ortiz-Virumbrales, Cesar L Moreno, Ilya Kruglikov, et al.
Molecular Neurodegeneration
|
December 19, 2009
Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo
John W Steele, Soong H Kim, John R Cirrito, et al.
Translational Psychiatry
|
March 17, 2022
Reduced cerebellar cortical thickness in World Trade Center responders with cognitive impairment
Sean A P Clouston, Minos Kritikos, Chuan Huang, et al.
Journal of Alzheimer'S Disease : JAD
|
August 14, 2022
DTI Connectometry Analysis Reveals White Matter Changes in Cognitively Impaired World Trade Center Responders at Midlife
Minos Kritikos, Chuan Huang, Sean A P Clouston, et al.
Page
of 20